Zobrazeno 81 - 90
of 337
pro vyhledávání: '"Jan Cerny"'
Publikováno v:
Journal of Medical Virology
The current pandemic due to coronavirus disease 2019 (COVID‐19) has posed an unprecedented challenge for the medical communities, various countries worldwide, and their citizens. Severe acute respiratory syndrome coronavirus 2 has been studied for
Autor:
Neil Palmisiano, Reinhold Munker, Siddhartha Ganguly, Wael Saber, Hillard M. Lazarus, Miguel Angel Diaz, Attaphol Pawarode, Taiga Nishihori, Partow Kebriaei, Jan Cerny, Jean-Yves Cahn, Nasheed Hossain, Sunita Nathan, Baldeep Wirk, Sachiko Seo, Melhem Solh, Brenda M. Sandmaier, Christopher Bredeson, Nelli Bejanyan, Gregory A. Hale, Jakob Passweg, Edward A. Copelan, Harry C. Schouten, Cesar O. Freytes, Hai-Lin Wang, David A. Rizzieri, Biju George, Daniel J. Weisdorf, Natasha Kekre, Michael R. Grunwald, Stefan O. Ciurea, Marcos de Lima, Sergio Giralt, Vera Ulrike Bacher, Marjolein van der Poel, Richard F. Olsson, Michael Byrne, Rodrigo Martino, Mark R. Litzow, Khalid Bo-Subait, Jean A. Yared, Mei-Jie Zhang, Christopher S. Hourigan, Christopher G. Kanakry, Bipin N. Savani, Mitchell S. Cairo, Gerhard C. Hildebrandt, Erica D. Warlick, Robert Peter Gale, Mohamed A. Kharfan-Dabaja, Steven D. Gore, Claudio G. Brunstein, Leo F. Verdonck, Ajoy Dias, Mahmoud Aljurf
Publikováno v:
Transplant Cell Ther
Transplantation and Cellular Therapy, 27(1). Elsevier
Transplantation and Cellular Therapy, 27(1). Elsevier
Compared with reduced-intensity conditioning (RIC), myeloablative conditioning (MAC) is generally associated with lower relapse risk after allogeneic hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) and myelodysplastic sy
Publikováno v:
Laboratory Medicine
The COVID-19 pandemic has led to a major setback in both the health and economic sectors across the globe. The scale of the problem is enormous because we still do not have any specific anti-SARS-CoV-2 antiviral agent or vaccine. The human immune sys
Autor:
Kamal Kant Sahu, Jan Cerny
Publikováno v:
Expert Review of Hematology
The outbreak of the coronavirus disease 2019 (COVID‐19) has posed an unprecedented challenge to the health care communities across the globe [1]. As of June 17th, 2020, a total of 8,339,829 confirm...
Publikováno v:
Journal of Medical Virology
The aim of the article was to discuss the current challenges for management of immune thrombocytopenia (ITP) during COVID-19 pandemic, based on the practical experience and interim expert recommendations suggested by the hematology societies Based on
Autor:
Diego Melgar, Maria Luisa Machain, Marcelo Lagos, Néstor Corona, María Teresa Ramírez-Herrera, Ericka Alinne Solano-Hernandez, Avto Goguitchaichvili, Jan Cerny, Ana Carolina Ruiz-Fernández, Margarita Caballero, María Ortuño, Rocío Castillo-Aja, Miriam L. Vazquez-Caamal
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Globally, instrumentally based assessments of tsunamigenic potential of subduction zones have underestimated the magnitude and frequency of great events because of their short time record. Historical and sediment records of large earthquakes and tsun
Publikováno v:
Transfusion Clinique et Biologique
The Coronavirus Disease-2019 (COVID-19) pandemic has trampled the health care system of many countries [1]. Blood transfusion services (BTS) in any hospital, hold the prime location and ensure smooth functioning of all elective and urgent surgical in
Autor:
Jayde Bednarik, Bennett E Vogt, Kriti Mittal, Lindsey Shanahan, Jonathan M. Gerber, Jan Cerny, A. Daniyal Siddiqui, Muthalagu Ramanathan, Xin Wang, Subramony Subramonia-Iyer, Saleem Khanani
Publikováno v:
Blood cells, moleculesdiseases. 85
Background Post-transplant maintenance provides progression-free survival benefit in multiple myeloma (MM). Here we report our institution's experience with elotuzumab-based maintenance following autologous stem cell transplant. Methods We retrospect
Publikováno v:
British Journal of Haematology
Coronavirus disease 19 (COVID‐19) has posed unparalleled challenges for health care communities, the general population, and in particular, for patients suffering from various comorbidities. Patients with hematological disorders, both benign and ma
Publikováno v:
Journal of Medical Virology
As of May 19, 2020, there are in total 4,986,200 laboratory‐confirmed Coronavirus disease‐2019 (COVID‐19) cases. 2% (45,425) out of 2,657,390 active COVID‐19 cases are critically ill and might be requiring intensive care support.(1,2) Unfortu